Pancreatic cancer resulted in 411,600 deaths globally in 2015. Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and it is highly lethal. Survival for patients with PDAC is dismal due to its aggressive nature, thus the development of novel and reliable prognostic model for early detection and therapy is much desired. Here we proposed a prognostic framework for prediction of overall survival of PDAC patients based on predictors derived from pancreas CT scans and patient clinical variables. Our framework includes three parts: feature extraction, feature selection and survival prediction. First, 2436 radiomics features were extracted from CT scans and were combined with the clinical variables, and a Cox model was fitted to each covariate individually to select the most predictive features. The optimal cut-off was determined by cross-validation. Finally, gradient boosting with component-wise Cox’s proportional hazards model was utilized to predict the overall survival of patients. Our framework achieves excellent performance on MICCAI 2018 Pancreatic Cancer Survival Prediction Challenge dataset, achieving mean concordance index of 0.7016 using five-fold cross-validation.


Pancreatic cancer Survival analysis Prognostic model 


  1. 1.
    Adamska, A., Domenichini, A., Falasca, M.: Pancreatic ductal adenocarcinoma: current and evolving therapies. Int. J. Mol. Sci. 18(7), 1338 (2017)CrossRefGoogle Scholar
  2. 2.
    Brennan, M.F., Kattan, M.W., Klimstra, D., Conlon, K.: Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann. Surg. 240(2), 293 (2004)CrossRefGoogle Scholar
  3. 3.
    Distler, M., Pilarsky, E., Kersting, S., Grützmann, R.: Preoperative CEA and CA 19–9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas-a retrospective tumor marker prognostic study. Int. J. Surg. 11(10), 1067–1072 (2013)CrossRefGoogle Scholar
  4. 4.
    van Griethuysen, J.J., et al.: Computational radiomics system to decode the radiographic phenotype. Cancer Res. 77(21), e104–e107 (2017)CrossRefGoogle Scholar
  5. 5.
    He, K., et al.: Component-wise gradient boosting and false discovery control in survival analysis with high-dimensional covariates. Bioinformatics 32(1), 50–57 (2015)Google Scholar
  6. 6.
    Siegel, R.L., Miller, K.D., Jemal, A.: Cancer statistics, 2017. CA: A Cancer J. Clin. 67(1), 7–30 (2017). Scholar
  7. 7.
    Oldfield, L.E., Connor, A.A., Gallinger, S.: Molecular events in the natural history of pancreatic cancer. Trends Cancer 3(5), 336–346 (2017)CrossRefGoogle Scholar
  8. 8.
    Rangarajan, V.: Three dimensional (3D) CT reconstruction in cancer imaging. Indian J. Med. Res. 137(1), 10–11 (2013)Google Scholar
  9. 9.
    Zhu, L., et al.: CT imaging biomarkers predict clinical outcomes after pancreatic cancer surgery. Medicine 95(5), e2664 (2016)CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  1. 1.Southern University of Science and TechnologyShenzhenChina

Personalised recommendations